Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Evotec and Roche collaborate on protein-activity based biomarkers for use in oncology

June 29, 2011

Jevtana/prednisone combination approved in Canada for prostate cancer

June 29, 2011

Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors

June 29, 2011

RG-7112 advances through clinical development for cancer

June 29, 2011

NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC

June 29, 2011

Arno Therapeutics reports interim phase II data on AR-67 in glioblastoma multiforme

June 28, 2011

FDA lifts clinical hold on phase II Cavatak trial in melanoma

June 28, 2011

Arch Cancer Therapeutics prepares new brain tumor-targeting peptides

June 28, 2011

First-in-human study reveals activity of RAF-265 in melanoma

June 28, 2011

First-in-human data disclosed on ONX-0912 in recurrent/refractory solid tumors

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...